SCHEMBL6186899

SCHEMBL6186899

CCCNS(=O)(=O)c1c(Cl)cccc1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.54
KMT2A Q03164 6/20 0.54
TP53 P04637 6/20 0.54
CYP1A2 P05177 5/20 0.54
CYP2C19 P33261 5/20 0.54
MEN1 O00255 5/20 0.54
TSHR P16473 4/20 0.54
TDP1 Q9NUW8 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.52
CA12 O43570 2/20 0.47
CA9 Q16790 2/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
POLB P06746 1/20 0.46
CYP2D6 P10635 4/20 0.44
CYP2C9 P11712 4/20 0.44
MAPK1 P28482 3/20 0.44
THPO P40225 3/20 0.44
NFKB1 P19838 2/20 0.44
CCR1 P32246 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9850210 0.80 CA12 (0.59) CYP3A4KMT2ATP53CYP1A2CYP2C19
SCHEMBL3683320 0.78 CYP3A4 (0.79) CYP3A4KMT2ATP53CYP1A2CYP2C19
SCHEMBL26075093 0.78 PKM (0.50) KMT2ACA12CA9CA1CA2
SCHEMBL21569706 0.77 L3MBTL1 (0.56) CYP3A4KMT2ATP53CYP1A2CYP2C19
SCHEMBL7052844 0.77 ATM (0.54) KMT2ATSHRL3MBTL1ATMALDH1A1
SCHEMBL1081882 0.76 POLB (0.40) CYP3A4KMT2ATP53CYP1A2CYP2C19
SCHEMBL6565726 0.76 CA12 (0.46) CYP3A4KMT2ATP53CYP1A2CYP2C19
SCHEMBL31500481 0.76 L3MBTL1 (0.51) CYP3A4KMT2ATP53CYP1A2CYP2C19
SCHEMBL2371626 0.74 ATM (0.50) KMT2AMEN1TDP1L3MBTL1CA12
SCHEMBL13296442 0.74 CYP3A4 (0.65) CYP3A4KMT2ATP53CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1521744-A1 ARYLSULPHONAMIDE DERIVATIVES AND USE THEREOF AS B1 BRADYKININ RECEPTOR ANTAGONISTS LABORATOIRES FOURNIER S.A. (FR) 2005-04-13 EP disclosed
WO-2003106428-A1 NOVEL ARYLSULPHONAMIDE DERIVATIVES AND USE THEREOF AS THERAPEUTIC AGENTS LABORATOIRES FOURNIER SA (FR) 2003-12-24 WO disclosed